[Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
Hisatome
Ichiro
I
Division of Molecular Medicine and Therapeutics, Tottori University Faculty of Medicine.
Ogino
Kazuhide
K
Igawa
Osamu
O
Shigemasa
Chiaki
C
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000009:adverse effects; D005198:Fanconi Syndrome / Q000139:chemically induced*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D033461:Hyperuricemia / Q000150:complications / Q000188:drug therapy*; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D007668:Kidney / Q000378:metabolism; D008019:Life Style; D011239:Prednisolone / Q000494:pharmacology; D014527:Uric Acid / Q000097:blood* / Q000378:metabolism; D014528:Uricosuric Agents / Q000494:pharmacology / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000890:Anti-Infective Agents; D014528:Uricosuric Agents; D014527:Uric Acid; D011239:Prednisolone